Document is current
Any future updates will be listed below
-
Authors
Plontke, S. K.
Götze, G.
Wenzel, C.
Rahne, T.
Mlynski, R.
- License Information
-
More Information
Article History
First Online: 28 July 2020
Compliance with ethical guidelines
:
: S.K. Plontke: Audio Cure Pharma GmbH, Berlin (consultancy); Oticon Medical, Denmark; Cochlear Ltd., Australia; Federal Ministry of Research and Education (Research Projects); BV-HNOe.V.; MerckSerono; Infectopharm; Dr.Willmar Schwabe GmbH& Co. KG, Deutschland (honrary for lectures and travel support for lectures). T. Rahne: Oticon Medical,Denmark; Cochlear Ltd., Australia (Research Projects). S.K. Plontke, G. Götze, C. Wenzel, T. Rahne, and R.Mlynski: MED-EL, Austria, and MED-EL Germany (Research Projects); MED-EL Austria and MED-EL Germany (travel support for lectures).
: All hearing rehabilitation procedures occured as routine treatment, after individual informed consent, and according to current ethical guidelines. The “off-label-use” of the implant in one patient (Figs. InternalRef removed and InternalRef removed) occured after special informed consent and on the specific request of the parents.
: The supplement containing this article is not sponsored by industry.
